C-terminal domain of insulin-like growth factor (IGF) binding protein-6: structure and interaction with IGF-II

被引:40
作者
Headey, SJ
Keizer, DW
Yao, SG
Brasuier, G
Kantharidis, P
Bach, LA
Norton, RS
机构
[1] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia
[2] Univ Melbourne, Austin Hosp, Dept Med, Heidelberg, Vic 3084, Australia
关键词
D O I
10.1210/me.2004-0248
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
IGFs are important mediators of growth. IGF binding proteins (IGFBPs) 1-6 regulate IGF actions and have IGF-independent actions. The C-terminal domains of IGFBPs contribute to high-affinity IGF binding and modulation of IGF actions and confer some IGF-independent properties, but understanding how they achieve this has been constrained by the lack of a three-dimensional structure. We therefore determined the solution structure of the C-domain of IGFBP-6 using nuclear magnetic resonance (NMR). The domain consists of a thyroglobulin type 1 fold comprising an alpha-helix followed by a loop, a three-stranded anti-parallel beta-sheet incorporating a second loop, and finally a disulfide-bonded flexible third loop. The IGF-II binding site on the C-domain was identified by examining NMR spectral changes upon complex formation. It consists of a largely hydrophobic surface patch involving the alpha-helix, the first beta-strand, and the first and second loops. The site was confirmed by mutagenesis of several residues, which resulted in decreased IGF binding affinity. The IGF-II binding site lies adjacent to surfaces likely to be involved in glycosaminoglycan binding of IGFBPs, which might explain their decreased IGF affinity when bound to glycosaminoglycans, and nuclear localization. Our structure provides a framework for understanding the roles of IGFBP C-domains in modulating IGF actions and conferring IGF-independent actions, as well as ultimately for the development of therapeutic IGF inhibitors for diseases including cancer.
引用
收藏
页码:2740 / 2750
页数:11
相关论文
共 53 条
[1]   Substitution of specific amino acids in insulin-like growth factor (IGF) binding protein 5 alters heparin binding and its change in affinity for IGF-I in response to heparin [J].
Arai, T ;
Clarke, J ;
Parker, A ;
Busby, W ;
Nam, T ;
Clemmons, DR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (11) :6099-6106
[2]   Insulin-like growth factor binding protein-6: The "forgotten" binding protein? [J].
Bach, LA .
HORMONE AND METABOLIC RESEARCH, 1999, 31 (2-3) :226-234
[3]  
BACH LA, 1993, J BIOL CHEM, V268, P9246
[4]   The insulin-like growth factor system: basic and clinical aspects [J].
Bach, LA .
AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1999, 29 (03) :355-361
[5]  
BACH LA, 1995, DIABETES REV, V3, P38
[6]   THE PROGRAM XEASY FOR COMPUTER-SUPPORTED NMR SPECTRAL-ANALYSIS OF BIOLOGICAL MACROMOLECULES [J].
BARTELS, C ;
XIA, TH ;
BILLETER, M ;
GUNTERT, P ;
WUTHRICH, K .
JOURNAL OF BIOMOLECULAR NMR, 1995, 6 (01) :1-10
[7]   Insulin-like growth factor (IGF)-binding proteins: interactions with IGFs and intrinsic bioactivities [J].
Baxter, RC .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2000, 278 (06) :E967-E976
[8]   The Protein Data Bank [J].
Berman, HM ;
Battistuz, T ;
Bhat, TN ;
Bluhm, WF ;
Bourne, PE ;
Burkhardt, K ;
Iype, L ;
Jain, S ;
Fagan, P ;
Marvin, J ;
Padilla, D ;
Ravichandran, V ;
Schneider, B ;
Thanki, N ;
Weissig, H ;
Westbrook, JD ;
Zardecki, C .
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 2002, 58 :899-907
[9]   Amino acids within the extracellular matrix (ECM) binding region (201-218) of rat insulin-like growth factor binding protein (IGFBP)-5 are important determinants in binding IGF-I [J].
Bramani, S ;
Song, H ;
Beattie, J ;
Tonner, E ;
Flint, DJ ;
Allan, GJ .
JOURNAL OF MOLECULAR ENDOCRINOLOGY, 1999, 23 (01) :117-123
[10]   MUTATIONS IN THE C-TERMINAL PART OF INSULIN-LIKE GROWTH-FACTOR (IGF)-BINDING PROTEIN-1 RESULT IN DIMER FORMATION AND LOSS OF IGF BINDING-CAPACITY [J].
BRINKMAN, A ;
KORTLEVE, DJ ;
ZWARTHOFF, EC ;
DROP, SLS .
MOLECULAR ENDOCRINOLOGY, 1991, 5 (07) :987-994